WallStreetZenWallStreetZen

NASDAQ: KURA
Kura Oncology Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

KURA earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$152.6M
Current Profit Margin
0%

KURA Return on Equity

Current Company
-36.3%
Current Industry
-63.5%
Current Market
188%
KURA's Return on Equity (-36.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when KURA announces earnings.

KURA Return on Assets

Current Company
-33.1%
Current Industry
2.9%
KURA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

KURA Return on Capital Employed

Current Company
-36.52%
Current Industry
19.5%
KURA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KURA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
KURA$0.00-$150.23M-$152.63MN/AN/A
ADMA$258.22M$5.12M-$28.24M+72.34%N/A
ARDX$124.46M-$55.65M-$66.07M+116.66%N/A
EWTX$0.00-$98.43M-$100.16MN/AN/A
PTGX$60.00M-$75.64M-$78.96M+14.17%N/A
View Top Biotech Stocks

KURA earnings dates

Next earnings date
Jun 5, 2024

Kura Oncology Earnings & Revenue FAQ

What were KURA's earnings last quarter?

On Invalid Date, Kura Oncology (NASDAQ: KURA) reported Q4 2023 earnings per share (EPS) of -$0.55, up 12.24% year over year. Total Kura Oncology earnings for the quarter were -$42.79 million. In the same quarter last year, Kura Oncology's earnings per share (EPS) was -$0.49.

If you're new to stock investing, here's how to buy Kura Oncology stock.

What was KURA's earnings growth in the past year?

As of Q2 2024, Kura Oncology's earnings has grown year over year. Kura Oncology's earnings in the past year totalled -$152.63 million.

What is KURA's earnings date?

Kura Oncology's earnings date is Invalid Date. Add KURA to your watchlist to be reminded of KURA's next earnings announcement.

What was KURA's revenue last quarter?

On Invalid Date, Kura Oncology (NASDAQ: KURA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Kura Oncology's revenue was $0.00.

What was KURA's revenue growth in the past year?

As of Q2 2024, Kura Oncology's revenue has grown null year over year. Kura Oncology's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.